Call for abstracts
EXTRA SESSION on the 2019 Novel Coronavirus

The WOHC2020 SARS-CoV-2 / COVID-19 special session is specifically calling for abstracts with an emphasis on

  • Pathogenesis and clinical manifestations
  • Virology and epidemiology
  • Intervention strategies (diagnostics, vaccines, antivirals, antibodies and biological response modifiers)
  • Clinical and outbreak management

Thursday June 18, 2020 13:00 - 14:30

Abstract deadline May 1, 2020

Current time and date CEST:

Submit your SARS-CoV-2 / COVID-19 abstract


Recent global disease events, like the outbreaks of Ebola, MERS and Zika, have underpinned the increasing impact of zoonotic diseases on human and animal health.

Download the full list of abstracts here

Abstract topics:

Determinants of inter-species and intra-species (including zoonotic) transmissibility of infectious agents

  • Environmental and ecological drivers (natural and human induced)
  • Socio-economic and political drivers
  • Host and pathogen determinants
  • Reservoir studies
  • Arthropod vectors: entomology, pathogen -(intermediate) host/ vector interaction/vector spread

Syndromic surveillance of infectious diseases in humans and animals

Pathogen discovery/identification platforms for humans and animals

Development of diagnostic assays for emerging infectious agents (including quality assurance and standardization)

Epidemiology and pathogenesis of newly emerging infections (including biosafety and biosecurity)

Mathematical modelling and scenario evaluation for risk assessment and economic/ disease burden impact

  • Intervention strategies in original host and in newly invaded species:
  • Isolation, quarantine, stamping out methods based on diagnostic/epidemiological data
  • Human and animal vaccine development and testing platforms
  • Antimicrobial drug discovery, development and testing platforms
  • Biological response modifier platforms (genomics, proteomics, NGS…)
  • Animal models
  • Mathematical modelling

Biological threat reduction including naturally occurring, accidentally or deliberately developed animal and human pathogens/control of biological agents

Advances in vaccine technologies and their impact in underprivileged communities / populations

Utilization of big data to mitigate biological threats and gathering epidemic intelligence

Cost-effectiveness of operational programmes of One Health / economic drivers / economic consequences (including trade issues)

Understanding the social context of One Health

Economic burden and impact of disease 

One Health in Sustainable Food Systems

Environmental and ecological issues

  • Climate change
  • Toxin exposure
  • Pollution
  • Geographic spread of diseases

Abstract topics

In September 2016, the World Health Organization officially stated that “antimicrobial resistance is a global societal challenge and threat”.

Download the full list of abstracts here

Abstract topics:

Burden and Impact of AMR 

  • AMR and global burden of disease
  • Global health security
  • Impact of AMR on animal production and food safety 
  • Impact of AMR on global trade 
  • Societal impacts from AMR
  • Economic impact

Transmission human, animal, environment

  • What has been achieved, what is the evidence?
  • Systems epidemiology of transmission 
  • Biosafety
  • Farm to fork to man and back, including agri- and aquaculture 
  • Waste management and impact on AMR transmission

Surveillance of AMR

  • Human (hospital, community), animal, environment
  • Use of whole genome sequencing for surveillance, one health microbiology, Global Microbial Identifier
  • Evolution of AMR 
  • Gene mobilization factors (including waste management)
  • Integrated AMR and antimicrobial use surveillance
  • Big data

Use of antibiotics 

  • AMR and use of antibiotics for growth promotion
  • Role of antibiotics (including food safety)
  • Antimicrobial treatment of emerging MDROs
  • Antimicrobial stewardship 
  • Infection prevention and control 
  • Access to antimicrobial medicines  
  • Quality of antibiotics

Policy interventions

  • Global policy interventions, IACG
  • National Action Plans
  • National/regional experience in reducing antimicrobial use: Efficiency and Effect
  • AMR and SDGs
  • Regulatory interventions 
  • Use of Big Data to guide interventions
  • Trade policy (impact on global trade)
  • Quality measures of antibiotics

New economic models

  • Push/pull incentives for antibiotic drug and diagnostic development 
  • Public private partnerships
  • Drug/Diagnostic partnerships
  • Economic impact assessment and modelling
  • Economic benefits
  • New models of trade

Behaviour Change and Social Sciences

  • Antimicrobial stewardship
  • Public perception and education in all One Health sectors
  • Socioeconomic barriers and cultural differences
  • Consumer behaviour and pressure
  • Serious gaming
  • Design thinking

Capacity building

  • Training the next generation
  • Building surveillance infrastructure
  • Implementation National Action Plans
  • One health approaches to teaching and training curricula 

Diagnostics and detection

  • Rapid, point of care, pen side diagnostics
  • Outbreak detection
  • Biomarkers of infection
  • Food safety and monitoring
  • Diagnostic stewardship

Antibiotic drug development and manufacturing

  • Design and implementation of efficient clinical trials for novel antibiotics
  • Development of new antimicrobials
  • Addressing bacterial cell wall permeability
  • Manufacturing in LMICS
  • Waste/waste water treatment

Alternative approaches to tackling resistant infections

  • Antibiotic alternatives (e.g. bacteriophages, immune modulators) 
  • Non-traditional approaches for humans and animals
  • Genome editing 
  • Animal models of disease

Vaccination as a tool in AMR reduction

  • Vaccines (against bacteria, viruses, etc)
  • Use of vaccines in animal husbandry and acquaculture
  • Cost and cost-benefit of vaccine use for growth promotion
  • Estimated/hypothesised decrease in antibiotic use from vaccines and or estimated cost/cost benefit
  • Licensing of vaccines for use in animals, poultry and fish

Abstract topics

The Science Policy Interface track is a tailor-made programme for public health officials and government representatives.

Download the full list of abstracts here

Abstract topics:

The impact of zoonotic diseases: why should One Health be of importance to policy makers?

Health emergencies: preparedness and management

  • Surveillance and outbreak response
  • Health crises and disasters

Addressing zoonotic diseases at the animal-human-ecosystem interface:  what are the threats of emerging zoonotic diseases?

Addressing zoonotic diseases at the animal-human-ecosystem interface:  what are the drivers of emerging zoonotic diseases?

Resistance to antibiotics and antivirals: challenges for policy makers and scientists

Operationalizing One Health

Intersectoral collaboration at global level as a key to prevention, preparedness and response strategies

Strengthening One Health Science and the Health Security interface

Strengthening national and regional epidemiological surveillance systems

Biological threat reduction in practice

Strengthening global biological security through collaborations and a better understanding of zoonotic origins

How can the public and private sectors take action and address disaster risk reduction?

Civil society participation

Risk communications

Community-driven development (CDD) projects and One Health

The role of vaccines in biological threat reduction

New initiatives to identify unknown viruses on a global scale

Advances in vaccine technologies and their impact on underprivileged communities

The global importance of pandemics for economic development

Economics of One Health

Bio threat scanning/scanning zoonotic diseases that could have the potential for misuse

Empowering Global Health Security and policy in Africa

Abstract topics

Submit your late-breaking abstract to the 6th World One Health Congress

The 6th World One Health Congress is the largest One Health event of the year, where experts and researchers from around the world present their latest scientific research.

The late-breaker category is exclusively devoted to novel and outstanding scientific discoveries, and aims at selecting abstracts with unique, high impact, ground breaking, innovative and newsworthy scientific data.

Thursday June 18, 2020 10:45 - 12:15

Abstract deadline May 1, 2020

Submit your late breaker abstract
Click to see the list of relevant topics
Abstract submission guidelines